|Articles|May 30, 2023

Chronic Pain, Opioids, and the Cannabis Industry: Perspectives from Nurse Practitioner Eloise Theisen

In this interview, Chief Nursing Officer and Board President of Leaf 411 Eloise Theisen shares her insights on medical cannabis.

Watch Eloise Theisen, NP, AGPCNP-BC, explain why she is eager to learn more about analytical testing in cannabis and dosages, what she is eager to share with her patients, and key takeaways from her recent presentation, “Using Cannabinoids to Reduce Daily Opioid Milligram Equivalent (OME) in Palliative Care Patients with Chronic Pain: Case Reviews."

This interview was filmed onsite at Cannabis Science Conference Spring 2023. For full coverage of the conference, read the highlights page here.


Related to this article

2025 Medical Cannabis Roundup
Let’s take a look at the 2025 cannabis coverage on medical cannabis research and medicine to catch up on industry trends and innovations.
Image | adobe.stock/Stock Rocket
Let’s take a look at the 2025 cannabis coverage on cannabis research to catch up on industry trends and innovations.
Manipulating Cannabis Genetics: Pulling Levers to Increase  Phytochemical Composition
Cannabis genetics fundamentally dictate the plant's potential for chemical signatures, including cannabinoid and terpene profiles, and physical traits, such as yield. Cultivators use selective techniques, such as "stacking," to enhance specific compounds. Ultimately, successful cultivation involves balancing superior genetics with environmental "levers" to optimize gene expression and create targeted strains.
Image | adobe.stock/Maksim Kabakou
It’s that time of year again—the Cannabis Science and Technology (CST) top 10 articles from the previous year. CST published a wide variety of content throughout 2025. Here is just a small snippet of some of the top articles that our readers enjoyed. See if any of your favorites made the list!